These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 16643608)

  • 41. Associations between renal sodium-citrate cotransporter (hNaDC-1) gene polymorphism and urinary citrate excretion in recurrent renal calcium stone formers and normal controls.
    Okamoto N; Aruga S; Matsuzaki S; Takahashi S; Matsushita K; Kitamura T
    Int J Urol; 2007 Apr; 14(4):344-9. PubMed ID: 17470169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic and physico-chemical urolithiasis parameters in the first morning urine.
    Serić V; Dutour-Sikirić M; Mihaljević I; Tucak-Zorić S; Bilić-Curcić I; Babić-Ivancić V
    Coll Antropol; 2009 Dec; 33 Suppl 2():85-92. PubMed ID: 20120404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strong inhibition of crystal-cell attachment by pediatric urinary macromolecules: a close relationship with high urinary citrate secretion.
    Miyake O; Kakimoto K; Tsujihata M; Yoshimura K; Takahara S; Okuyama A
    Urology; 2001 Sep; 58(3):493-7. PubMed ID: 11549512
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary calcium oxalate saturation in healthy infants and children.
    Hoppe B; Jahnen A; Bach D; Hesse A
    J Urol; 1997 Aug; 158(2):557-9. PubMed ID: 9224359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary metabolic evaluations in normal and stone forming children.
    DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E
    J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
    J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute effects of calcium sodium citrate supplementation of a test meal on mineral homeostasis, oxalate, and calcium oxalate crystallization in the urine of healthy humans--preliminary results in patients with idiopathic calcium urolithiasis.
    Herrmann U; Schwille PO; Schmiedl A; Fan J; Manoharan M
    Biomed Pharmacother; 1999 Jun; 53(5-6):264-73. PubMed ID: 10424248
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary metabolic evaluation of stone formers-a Malaysian perspective.
    Hong YH; Dublin N; Razack AH; Mohd MA; Husain R
    Urology; 2012 Sep; 80(3):529-34. PubMed ID: 22578827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Erythrocyte oxidative stress in patients with calcium oxalate stones correlates with stone size and renal tubular damage.
    Ma MC; Chen YS; Huang HS
    Urology; 2014 Feb; 83(2):510.e9-17. PubMed ID: 24360074
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK; Sutton RA
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The most important factor for active urinary stone formation in patients with urolithiasis].
    Simić-Ogrizović S; Dopsaj V; Jovicić S; Milenković D; Jovanović D; Nesić V
    Med Pregl; 2007; 60 Suppl 2():117-20. PubMed ID: 18928175
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
    Clin Chim Acta; 2005 Oct; 360(1-2):141-50. PubMed ID: 15992786
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concentration of a potent calcium oxalate monohydrate crystal growth inhibitor in the urine of normal persons and kidney stone patients by ELISA-based assay system employing monoclonal antibodies.
    Moghadam MF; Tandon C; Aggarwal S; Singla SK; Singh SK; Sharma SK; Varshney GC; Jethi RK
    J Cell Biochem; 2003 Dec; 90(6):1261-75. PubMed ID: 14635198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A simple method for quantitating the propensity for calcium oxalate crystallization in urine.
    Wabner CL; Pak CY
    J Lithotr Stone Dis; 1991 Jul; 3(3):255-9. PubMed ID: 11536933
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
    Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
    J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.